[CLSTR]
< Back to situations

[ORGANIZATION]

Pfizer Inc.

Featured in 18 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [US] [BR] [DK]

Novo Nordisk pivots strategy to counter patent cliff

107 clusters · 523 sources · last updated

Latest: Novo Nordisk pivots strategy amid semaglutide patent cliff concerns

Novo Nordisk is implementing a strategic reset to address long-term growth concerns and the looming patent expiration of semaglutide, the active ingredient in Ozempic and Wegovy. During a 2026 Capital Markets Day in Lond

[QUIET] [TECHNOLOGY] [US] [GB] [JP]

AI integration in drug discovery and biotechnology

3 clusters · 12 sources · last updated

Latest: TPC Marketing Research reports on AI drug discovery business strategies

The pharmaceutical and biotechnology sectors are increasingly integrating generative artificial intelligence to accelerate drug discovery and molecular design. Pfizer has entered a licensing agreement with Chai Discover

Also covered in